Coconut Oil: Managing Radiation-Induced Xerostomia
Coconut Oil as a Novel Approach to Managing Radiation-Induced Xerostomia: An Interventional Study
1 other identifier
interventional
30
1 country
1
Brief Summary
This study will seek to assess the experience of using of coconut oil as an approach to managing radiation-induced xerostomia in patients previously treated for cancer in the head and neck. There is a high prevalence of radiation-induced xerostomia in this patient population, and the condition has significant negative impact on patients' quality of life. There is currently no agreed-upon standard of care for the treatment of this condition. Anecdotal evidence from patients and both physicians and allied healthcare providers suggests improvement in this condition with the use of coconut oil, but this has not previously been formally studied. We therefore propose a case series study to formally assess the tolerability and efficacy of coconut oil as an approach to managing radiation-induced xerostomia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 1, 2017
CompletedFirst Posted
Study publicly available on registry
June 5, 2017
CompletedStudy Start
First participant enrolled
October 5, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
September 15, 2018
CompletedApril 17, 2018
April 1, 2018
8 months
May 1, 2017
April 13, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Subjective benefit
Our primary outcome of interest will be descriptive in nature, namely whether patients find subjective benefit from the use of coconut oil, as evidenced by its continued use throughout the study period. This will be appraised qualitatively by analyzing diary entries.
3 months
Secondary Outcomes (5)
Quality of Life
3 months
Change in Activities of Daily Living as assessed clinically at follow up appointment and as measured by the Xerostomia-related quality of life scale (XeQOLS).
3 months
Speech as assessed clinically at follow up appointment and as measured by the Xerostomia-related quality of life scale (XeQOLS).
3 months
Dysphagia as assessed clinically at follow up appointment and by way of the XeQOLS.
3 months
Coconut Oil
2 weeks or more
Study Arms (1)
Coconut Oil
EXPERIMENTALThrough a interventional/cohort design, we propose to study the experience of coconut oil over a three month period, allowing patients to use Biotene© oral lubricant (or another product of their choice) as an alternative to coconut oil if they so prefer.
Interventions
Eligibility Criteria
You may qualify if:
- Patient has completed treatment for head and neck cancer at least 18 months prior to entry to the study.
- Patient has experienced xerostomia following completion of radiation treatment.
- Patient has received external beam radiation at a dose of at least 50 Gy to the head and neck.
- Patients able to read / understand English.
- Patients who are competent/willing to consent to the study.
- Patients willing to comply with protocol and study schedule.
You may not qualify if:
- Patient currently undergoing treatment for head and neck cancer.
- Patient has previously used coconut oil for the treatment of xerostomia.
- Patient with allergy/sensitivity to coconut.
- Patient cannot read/ understand English.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Ottawa Hospital
Ottawa, Ontario, K1H8L6, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stephanie Johnson-Obaseki, MD
The Ottawa Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 1, 2017
First Posted
June 5, 2017
Study Start
October 5, 2017
Primary Completion
June 15, 2018
Study Completion
September 15, 2018
Last Updated
April 17, 2018
Record last verified: 2018-04
Data Sharing
- IPD Sharing
- Will not share